Management of hepatitis B virus infection, updated Swedish guidelines
Open Access
- 15 October 2019
- journal article
- review article
- Published by Informa UK Limited in Infectious Diseases
- Vol. 52 (1), 1-22
- https://doi.org/10.1080/23744235.2019.1675903
Abstract
Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and death. Early diagnosis, proper management and timing of treatment are crucial. The Swedish Reference group for Antiviral Treatment (RAV) here provides updated evidence-based guidelines for treatment and management of HBV infection which may be applicable also in other countries. Tenofovir alafenamide (TAF) has been introduced as a novel treatment option and new principles regarding indication and duration of treatment and characterization of hepatitis B have been gradually introduced which justifies an update of the previous guidelines from 2007. Updated guidelines on HCC surveillance in HBV-infected patients, treatment and prophylaxis for patients undergoing liver transplantation as well as management of pregnant women and children with HBV infection are also provided.Keywords
This publication has 81 references indexed in Scilit:
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2011
- Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescentsJournal of Hepatology, 2010
- Hepatocellular carcinoma in individuals with HBV infection or HBV–HCV co-infection in a low endemic countryScandinavian Journal of Gastroenterology, 2010
- Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burdenJournal of Viral Hepatitis, 2009
- Viral Hepatitis in HIV InfectionNew England Journal of Medicine, 2007
- A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis BNew England Journal of Medicine, 2006
- Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29-year longitudinal studyHepatology, 2006
- Hepatitis B virus genotypes and extrahepatic manifestationsJournal of Hepatology, 2005
- High carrier rate after hepatitis B virus infection in the elderlyHepatology, 1993